US 12006348
T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof
granted A61KA61K2039/605A61K2039/64
Quick answer
US patent 12006348 (T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/605, A61K2039/64, A61K38/00, A61K39/385